BREYANZI
BREYANZI
Approved
DIN Number
02527138
Drug Class
Human
Market Date
Nov 19, 2024
Company
HC
bristol-myers squibb canada
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02527138
AIG Number0163641001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L01XL08 LISOCABTAGENE MARALEUCEL
Product Specifications
Dosage FormSuspension
Route of AdministrationIntravenous
AHFS Classification26:12.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
LISOCABTAGENE MARALEUCELActive
Strength: 120000000 CELLS
Monograph: LISOCABTAGENE MARALEUCEL